Breaking

Rodríguez defends Venezuela’s emergency earthquake response as number of bodies expected to soar Australia give improved England plenty to ponder one year out from Ashes Jannik Sinner swats aside Mochizuki to reach Wimbledon quarter-finals How Osaka pulled off the upset over Sabalenka -- a... ‘They’ve tried to kill me for 23 years’: Cristiano Ronaldo says this World Cup will be his last Troy keeps season alive, ousts Ole Miss at MCWS Could Farage quit? Questions swirl over Reform UK leader’s future At least 25 people die in US as record heatwave scorches swaths of country National Guard members on patrol in Memphis fatally shoot man during pursuit, police say Delta pilot reports a close encounter with a July Fourth firework before landing in Chicago

NEWSREEL

The day, in 30-second reels.

--:--:--

Science / Reel

Science · Video brief

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

The Guardian· Jun 18, 2026 · 2:35 PM · 5 views

Discover how mRNA technology is revolutionizing flu prevention with Moderna's new vaccine, mFlusiva. Targeted at those 50 and older, this vaccine promises quicker production and better efficacy against flu mutations. Learn about the controversies and the potential impact as experts evaluate its effectiveness. #mRNA #FluVaccine #Moderna #FDA #HealthInnovation

Originally reported by The Guardian. Read the full story →

0 Comments

No comments yet. Be the first.

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

More in Science

The Guardian view on gene-edited humans: darker uses must be acknowledged alongside medical ones | Editorial

Bomb the Arctic, dam the Mediterranean and build a second moon: five outlandish plans to remodel our climate

Elon Musk posted twice as often on UK race and immigration as about SpaceX in IPO run-up

0 Comments